Arzneimittel-Rabattverträge ab 01.02.2026 zu diversen Wirkstoffen im Rahmen eines Open-House-Verfahrens
Alfacalcidol (A11CC03)
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
January 31, 2026 at 11:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
Aripiprazol (N05AX12), ohne Tabletten, Schmelztabletten, Lösungen zum Einnehmen
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
January 31, 2026 at 11:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
Atenolol (C07AB03)
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
January 31, 2026 at 11:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
Betahistin (N07CA01)
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
January 31, 2026 at 11:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
Cilostazol (B01AC23)
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
January 31, 2026 at 11:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
Colecalciferol (A11CC05) ohne rezeptpflichtige Produkte
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
January 31, 2026 at 11:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
Flecainid (C01BC04)
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
January 31, 2026 at 11:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
Glatirameracetat (L03AX13)
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
January 31, 2026 at 11:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
Granisetron (A04AA02), nur transdermale Pflaster
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
January 31, 2026 at 11:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
Lactulose (A06AD11)
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
January 31, 2026 at 11:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
Lamivudin & Abacavir (J05AR02)
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
January 31, 2026 at 11:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
L-Thyroxin-Natrium (H03AA01)
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
January 31, 2026 at 11:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
Mycophenolsäure (L04AA06), ohne feste orale Darreichungsformen
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
January 31, 2026 at 11:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
Olmesartanmedoxomil & Hydrochlorothiazid (C09DA28)
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
January 31, 2026 at 11:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria
Paliperidon (N05AX13), nur Trevicta
CPV: 33600000-6 - Pharmaceutical products
Estimated value
Offer deadline
January 31, 2026 at 11:00 PM
Quantity
1
Contract value
Not specified
Award criteria
0 criteria